Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts.

The Karnataka High Court has stayed an advisory issued by the Food Safety and Standards Authority of India (FSSAI) banning the use of Ashwagandha leaves or extracts in supplements due to safety concerns flagged by the Union Ministry of Ayush.

Justice S R Krishna Kumar Tuesday said, “The impugned advisory dated 16.04.2026 issued by the respondents is hereby stayed only insofar as it relates to the petitioners in W.P.No.14990/2026 and W.P.No.15010/2026 are concerned, till the next date of hearing.”

The interim order was passed in response to petitions filed by Sami-Sabinsa Group Ltd and Kerry Inc, which approached the court seeking to quash the advisory.

Ashwagandha, as an adaptogen, is commonly marketed as a natural supplement to boost strength and sexual wellness, particularly among men, and is available in various forms. Ashwagandha leaves allegedly contain higher levels of reactive withanolides, particularly withaferin-A, that pose safety risks including liver toxicity, gastrointestinal distress, and potential neurotoxic effects.

Senior Advocate K G Raghavan, appearing for the petitioners, argued that the companies are engaged in the manufacture of their products through contract manufacturers of Ashwagandha.

Further it was said that the manufacturing of Ashwagandha from the roots and extracts of the plant including leaves is being done as per norms laid down under Food Safety and Standards (Health Supplements, Neutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016, which are framed under Section 92 of the Food Safety and Standards Act, 2006.

Raghavan also pointed out that the prohibition of the usage of certain parts of a food supplement cannot be issued through a mere advisory, without amending the 2016 Regulations. Moreover, the companies have been manufacturing their products using the leaves of the Ashwagandha plant for more than 30 years.

Related Posts

Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

Green dot or red dot? Soaps, shampoos and toothpaste to reveal if they are veg or non-veg That green dot you usually look for on a food packet could soon…

Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

The Drugs Control Department has seized counterfeit rabies vaccine worth about ₹2 lakh from a firm in Chandni Chowk’s Bhagirath Palace, the Delhi government said on Tuesday. Health Minister Pankaj…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

AIIA organises public awareness rally on 11th Ayurveda Day

AIIA organises public awareness rally on 11th Ayurveda Day

UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance